These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8809648)

  • 1. Application of population pharmacokinetics to the optimization of theophylline therapy.
    Otero MJ; Buelga DS; Vázquez MA; Barrueco M; Dominguez-Gil A
    J Clin Pharm Ther; 1996 Apr; 21(2):113-25. PubMed ID: 8809648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea.
    Fukuda T; Yukawa E; Kondo G; Maeda T; Shin-o T; Kondo Y; Imamura T; Irikura M; Irie T
    J Clin Pharm Ther; 2005 Dec; 30(6):591-6. PubMed ID: 16336292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysis].
    Li Z; Chen G
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):267-70. PubMed ID: 7976385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline clearance: effect of marked obesity.
    Blouin RA; Elgert JF; Bauer LA
    Clin Pharmacol Ther; 1980 Nov; 28(5):619-23. PubMed ID: 7438680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of passive smoking on theophylline clearance in children.
    Mayo PR
    Ther Drug Monit; 2001 Oct; 23(5):503-5. PubMed ID: 11591894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and efficacy of slow-release theophylline with asymmetric dosing in asthmatic Chinese.
    Pang JA; Zhang YG; Swaminathan R
    Chest; 1988 Apr; 93(4):785-9. PubMed ID: 3349835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models.
    Driscoll MS; Ludden TM; Casto DT; Littlefield LC
    J Pharmacokinet Biopharm; 1989 Apr; 17(2):141-68. PubMed ID: 2795453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline pharmacokinetics with concomitant steroid and gold therapy.
    Falcão AC; Rocha MJ; Almeida AM; Caramona MM
    J Clin Pharm Ther; 2000 Jun; 25(3):191-5. PubMed ID: 10886464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease.
    Ma Y; Xue L; Chen X; Kang Y; Wang Y; Wang L
    Int J Clin Pharm; 2018 Oct; 40(5):1010-1018. PubMed ID: 29777329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state population pharmacokinetics of sustained release theophylline in adult asthmatic patients.
    Thomas G; Koen R; Houze P; Lagier G; Gervais P
    Fundam Clin Pharmacol; 1991; 5(7):611-9. PubMed ID: 1778539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E; Baba M
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic/pharmacodynamic modeling of theophylline in patients with different degrees of airway obstruction.
    Flores-Murrieta FJ; Mercado DE; Rodríguez-Silverio J; Chapela R
    Proc West Pharmacol Soc; 1999; 42():3-4. PubMed ID: 10697671
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of theophylline metabolism by aciclovir.
    Maeda Y; Konishi T; Omoda K; Takeda Y; Fukuhara S; Fukuzawa M; Ohune T; Tsuya T; Tsukiai S
    Biol Pharm Bull; 1996 Dec; 19(12):1591-5. PubMed ID: 8996645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of theophylline. II: Intravenous infusion to patients with stable chronic airway obstruction.
    Yano I; Tanigawara Y; Yasuhara M; Okumura K; Kawakatsu K; Nishimura K; Hori R
    Biol Pharm Bull; 1993 May; 16(5):501-5. PubMed ID: 8364499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline.
    Barnes PJ
    Am J Respir Crit Care Med; 2013 Oct; 188(8):901-6. PubMed ID: 23672674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population pharmacokinetics of theophylline in neonates and young infants.
    Moore ES; Faix RG; Banagale RC; Grasela TH
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):47-66. PubMed ID: 2715932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of theophylline. III. Premarketing study for a once-daily administered preparation.
    Tanigawara Y; Komada F; Shimizu T; Iwakawa S; Iwai T; Maekawa H; Hori R; Okumura K
    Biol Pharm Bull; 1995 Nov; 18(11):1590-8. PubMed ID: 8593486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of intravenous theophylline in asthmatic children: Bayesian approach vs direct pharmacokinetic calculations.
    el Desoky E; Ghazal MH; Mohamed MA; Klotz U
    Jpn J Pharmacol; 1997 Sep; 75(1):13-20. PubMed ID: 9334881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of pyrexia and age on theophylline clearance in young children with asthma.
    Imai K; Munehisa Y; Yoshikuni Y; Morita T; Nomura H; Kimura Y; Mimaki Y; Kihira K
    Hiroshima J Med Sci; 2012 Mar; 61(1):15-8. PubMed ID: 22702215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.
    Navid A; Ng DM; Wong SE; Lightstone FC
    CPT Pharmacometrics Syst Pharmacol; 2016 Feb; 5(2):74-81. PubMed ID: 26933518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.